ArticleEuropean journal of nuclear medicine and molecular imaging2024

Challenges coexist with opportunities: development of a macrocyclic peptide PET radioligand for PD-L1.

Wenpeng Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.